• News
  • Stock Screener
  • Small Caps
  • Guru Portfolios
  • Review
  • News
  • Stock Screener
  • Small Caps
  • Guru Portfolios
  • Review
  • X (Twitter)
  • LinkedIn
Stock Screener·Saudi Arabia·Healthcare·4004.SR
Share

Dallah Healthcare Company Stocks

SAR 106.6Last Updated 11.06.2026

Issuer Rating

6/7
Performance

Favourable

Risk

Low

Recommendation

Buy

Market Cap

SAR 2.92B

SAR 106.6
Key Takeaways

Risk factor

Negligible price volatility

Data is available to registered users only
Data is available to registered users only

Profitability factor

Decent dividends

Data is available to registered users only
Data is available to registered users only
Sign up to get free access to key risk and return factors, detailed company valuation, and analyst forecasts
Sign up to access all the key risk and return factors

Risks

  • Default risk
    Data is available to registered users only
  • Volatility
    Data is available to registered users only
  • Selling difficulty
    Data is available to registered users only
  • Stress test
    Data is available to registered users only
  • Country risks
    Data is available to registered users only
  • Other risks
    Data is available to registered users only
Sign up to access detailed risk analysis

About

Operating within the Kingdom of Saudi Arabia, Dallah Healthcare Company specializes in delivering and managing a comprehensive array of healthcare services and infrastructure. Its core activities encompass the operation, management, outfitting, and growth of hospitals, various medical establishments, polyclinics, residential healthcare complexes, and associated land. Additionally, it supplies essential personnel and ancillary services to both hospitals and medical centers. Beyond direct healthcare provision, Dallah Healthcare is also involved in the production and supply of pharmaceutical, herbal, and cosmetic goods, distributing them to individual pharmacies, health and beauty retailers, hospitals, and government bodies. The firm further extends its expertise to include the oversight and running of hospitals belonging to external entities, alongside offering various supplementary support functions. This encompasses the administration of private hospitals, specialized medical and diagnostic centers, and an analytical laboratory, coupled with the direct provision of medical care. Originally established as Dallah Healthcare Holding Company, the organization officially adopted its current name, Dallah Healthcare Company, in November 2016. Founded in 1994, its corporate headquarters are situated in Riyadh, Saudi Arabia, and it operates as a subsidiary of Dallah Al-Barakah Holding.

Company Valuation

Fairly valued
4/7

From both historical and forecast perspectives, the stock is fairly priced compared to similar stocks. Specifically, the stock is fairly valued on P/E, neutral on EV/EBIT

Data is available to registered users only
Sign up to access detailed valuation

Target Price

Somewhat favourable
5/7

The average target price of 4004.SR is 132 and suggests 23% upside potential. Usually, this means a BUY recommendation among investment firms, or a recommendation to incr

Data is available to registered users only
Sign up to access analyst forecasts

Risks

  • Default risk
    Data is available to registered users only
  • Volatility
    Data is available to registered users only
  • Selling difficulty
    Data is available to registered users only
  • Stress test
    Data is available to registered users only
  • Country risks
    Data is available to registered users only
  • Other risks
    Data is available to registered users only
Sign up to access detailed risk analysis

Trending

13.06.2026 16:01

Highlights in small-caps: record IPO in biotech, Wizz Air success, SpaceX effect

13.06.2026 13:01

An investment idea for all times, IPO of the year and how to keep emotions in check in the stock market

13.06.2026 03:02

Microsoft is considering spinning off Xbox into a separate company - The Information

13.06.2026 01:40

Hope for peace with Iran and SpaceX lifted spirits: stocks rose for second straight day

13.06.2026 01:05

SpaceX shares rose in value by 19% on the first day of trading. Is it worth buying them?

X-channel

Buy

Sell

0 more stocks

Company

  • About
  • Contributors
  • Contacts
  • Legal Information

Social media

  • X (Twitter)
  • LinkedIn
  • X (Twitter)
  • LinkedIn
Oninvest© 2026